High-dose-rate brachytherapy at 3 Gy per fraction for lip carcinoma: Treatment outcomes and toxicity at 5-years

Low-dose-rate brachytherapy (LDR-BT) is a well-established treatment for lip cancer. High-dose-rate (HDR)-BT is a promising alternative to LDR-BT, but data are limited. In this context, we retrospectively evaluated treatment outcomes in a series of patients who underwent HDR-BT for lip carcinoma between 2003 and 2021.

Source: Brachytherapy - April 2, 2023 Category: Cancer & Oncology Authors: Lubo š Tuček, Igor Sirák, Miroslav Hodek, Linda Kašaová, Jakub Grepl, Petr Paluska, Denisa Pohanková, Libor Hruška, Milan Vošmik, Jiří Petera Tags: Head and Neck Source Type: research